Internal Medicine, Infectious Disease · Celina, OH
NPI
1811936198
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
950 S Main St Ste A
Celina, OH, 45822
Phone (419) 586-9657
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,241 services
Medicare patients, 2024
312
Average age 71
Drug cost, 2024
$826K
805 prescriptions
Company payments, 2025
$823
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wilfred J Ellis was code 99232 (hospital e&m - subsequent), 417 times for 112 patients. In total Wilfred J Ellis billed 1,241 services in 36 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 417 | 112 | $59.15 | $25K |
| 99213 Office E&M - Established | Office | 364 | 150 | $46.70 | $17K |
| 99222 Hospital E&M - Initial | Facility | 173 | 144 | $97.38 | $17K |
| 99214 Office E&M - Established | Office | 67 | 39 | $70.23 | $4,706 |
| 99203 Office E&M - New | Office | 66 | 66 | $59.31 | $3,914 |
| 99204 Office E&M - New | Office | 16 | 16 | $88.13 | $1,410 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $130.62 | $1,567 |
By year: 2022 $79K for 1,357 services; 2023 $73K for 1,256 services; 2024 $77K for 1,241 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wilfred J Ellis prescribed most often to Medicare patients was Cefadroxil, with 82 prescriptions and refills. In total Wilfred J Ellis wrote 805 Medicare prescriptions that cost $826K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cefadroxil Generic | 82 | 89 | 46 | $1,185 |
| Ciprofloxacin Hcl Generic | 52 | 56 | 36 | $316 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 49 | 49 | Under 11 | $192K |
| Fluconazole Generic | 40 | 44 | 19 | $1,581 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 40 | 13 | $200 |
| Doxycycline Hyclate Generic | 32 | 34 | 23 | $425 |
| Delstrigo Doravirine/Lamivu/Tenofov Diso | 31 | 31 | Under 11 | $88K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 30 | 30 | 26 | $432 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 30 | 35 | 18 | $526 |
| Triamcinolone Acetonide Generic | 25 | 31 | Under 11 | $135 |
| Ceftriaxone Ceftriaxone Sodium | 24 | 24 | Under 11 | $4,029 |
| Stribild Elviteg/Cob/Emtri/Tenofo Disop | 24 | 24 | Under 11 | $91K |
| Isentress Raltegravir Potassium | 19 | 19 | Under 11 | $35K |
| Cephalexin Generic | 16 | 22 | Under 11 | $178 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 15 | 22 | Under 11 | $12K |
Brand drugs: 206 claims; generic drugs: 599 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wilfred J Ellis $823 ($823 in general payments such as food, travel and fees) from 13 companies. The largest payer was Gilead Sciences, Inc. with $168.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 11 | $168 |
| Abbvie Inc. ABBV | 2 | $161 |
| Merck Sharp & Dohme LLC MRK | 5 | $95.26 |
| ViiV Healthcare Company GSK | 3 | $72.33 |
| CSL Behring CSL.AX | 3 | $61.46 |
| Smith+Nephew, Inc. SNN | 2 | $56.75 |
| Insmed, Inc. INSM | 3 | $48.79 |
| Aimmune Therapeutics, Inc. | 2 | $38.69 |
| Organogenesis Inc. ORGO | 2 | $37.18 |
| Ferring Pharmaceuticals Inc. | 1 | $29.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.